Facebook
Twitter
LinkedIn
Forward
This session will be an overview of assessment and treatment options for children with special needs or medical complexity who also suffer from obesity.
|
There is a marked variation in individual patient response to interventions designed to treat obesity and adiposity related diseases.
|
Over the last decade, the FDA has approved five new medications for the treatment of obesity. The latest edition, semaglutide, published impressive weight loss results and we are just beginning.
|
The Essentials of Anti-Obesity Medications - A Case-Based ApproachCME/CE Expiration Date: 3/22/25
|
Our patients frequently ask if they should take CBD to assist with weight loss.
|
Akkermansia muciniphila, a key player in the gut microbiome, has emerged as a significant influencer of GLP-1, a hormone with profound implications for metabolic health.
|
Many factors influence a patient's weight loss journey including metabolism, genetics, lifestyle, and other biological and cultural differences.
|
Join us for an informative session designed to enhance your expertise in prescribing GLP1 medications for the treatment of obesity.
|
As the choices available for anti-obesity pharmacotherapy increase, clinicians are faced with options for addressing key clinical scenarios.
|
Obesity is a metabolic disease that requires lifelong lifestyle changes and in many patients who are overweight or obese, prescription medication.
|